Shareholder Class Action

Javelin Pharmaceuticals is selling itself too cheaply to Myriad Pharmaceuticals, in an all-stock deal valued at $91 million, shareholders claim in Middlesex County Court, Woburn, Mass.

     
     Rentech propped up its stock price through false and misleading statements, shareholders claim in Los Angeles Federal Court.

%d bloggers like this: